Prostigmin

Active Ingredient(s): Neostigmine
Category: Myasthenic Syndrome



Prostigmin Overview

Neostigmine is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage.[2][3] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.[2] It is given by injection either into a vein, muscle, or under the skin.[2] After injection effects are generally greatest within 30 minutes and last up to 4 hours...

Read more Prostigmin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Neostigmine

Recent Prostigmin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Neostigmine
  • Injection: 0.25mg/ml, 0.5mg/ml, 1mg/ml
  • Solution: 10mg/10ml (1mg/ml), 5mg/10ml (0.5mg/ml)
  • Tablet: 15mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Prostigmin: (1 result)

Sorted by National Drug Code
  • 0187-3100 Prostigmin Bromide 15 mg Oral Tablet by Valeant Pharmaceuticals North America LLC

Other drugs which contain Neostigmine or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA